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Abstract (200 words or less) 23 
Globally, the eradication of bovine viral diarrhoea virus (BVDV) is still in its infancy 24 
but eradication has been, or is being, adopted by several countries or regions. 25 
Comparisons between countries’ schemes allow others to assess best practice, and 26 
aggregating published results from eradication schemes provides greater statistical 27 
power when analysing data. Aggregating data requires that results derived from 28 
different testing schemes be calibrated against one another. We aimed to evaluate 29 
whether relationships between published BVDV test results could be created and 30 
present the outcome of a systematic literature review following the Preferred 31 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. 32 
The results are tabulated, providing a summary of papers where there is potential 33 
cross-calibration and a summary of the obstacles preventing such data-aggregation. 34 
Although differences in measuring BVDV present barriers to academic progress they 35 
may also affect progress within individual eradication schemes. We examined the 36 
time taken to retest following an initial antibody BVDV test in the Scottish eradication 37 
scheme. We demonstrate that retesting occurred quicker if the initial not negative 38 
test was from blood rather than milk samples. Such differences in the response of 39 
farmers/veterinarians to tests may be of interest to the design of future schemes.  40 
 41 
Word Count: 199  42 
 43 
  44 
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Introduction 45 
Programs designed to eradicate bovine viral diarrhoea virus (BVDV) appear, overall, 46 
to be making progress, and they exist in various countries (AHI 2014, AHWNI 2014, 47 
Barrett and others 2011, Graham and others 2014, Lindberg and others 2006, Presi 48 
and others 2011, Sandvik 2004). Other programs are also planned (Farmers Weekly 49 
2014, Laurens, 2014).  The variation in the design of these existing programs is of 50 
use in designing future programs because it allows comparison of different strategies 51 
and lessons to be learnt. The publication of results from different programs around 52 
the world also provides a potential opportunity for combining data or results to 53 
increase the statistical power when testing scientific hypotheses (Egli 2014). 54 
 55 
In Scotland, the eradication of BVDV is on its fourth stage (Scottish Government 56 
2014a). The majority of eradication programs attempt to split herds into ‘possibly 57 
infected’ and ‘uninfected’ (Lindberg and others 2006, Prezi and others 2011). In 58 
Scotland the two categories are labelled as ‘not negative’ and ‘negative’. Negative 59 
herds continue to be monitored in case their status changes. Not negative herds 60 
should initiate further testing, commonly trying to find persistently infected (PI) 61 
animals and have their movements restricted (Scottish Government 2014b).  62 
 63 
Within the Scottish BVDV eradication scheme there are eight possible testing 64 
methods (including three types of calf sampling) and eight groups of laboratories that 65 
can process the tests (Scottish Government 2015a, Scottish Government 2015b). 66 
Samples may be tissue, semen, blood or milk and can be tested for antigen or 67 
antibody (Scottish Government 2014c).  68 
 69 
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For dairy herds, bulk milk samples are common in eradication schemes to identify 70 
antibody status with antigen blood testing frequently used to establish whether the 71 
herd is currently infected and to find PI animals. For beef herds, blood testing 72 
predominates. The difference between common types of bulk milk and blood tests 73 
provides a useful example of the ramifications of differences in tests. 74 
 75 
Within each sampling method (as described above) there are also many different 76 
laboratory tests for BVDV (Lanyon and others 2014a) and a comprehensive list of 77 
those available is beyond the scope of this paper. Many of the tests available are 78 
based on detection of the virus or the antibody to the virus, and use enzyme-linked 79 
immunosorbent assay (ELISA), immunohistochemical tests, reverse transcription 80 
polymerase chain reaction (RT-PCR), or neutralization serum antibody tests 81 
(Radostits and others 2007). The variation in test regime depends upon a 82 
combination of the particular kit manufacturer, the sampling regime and the tissues 83 
sampled. 84 
 85 
Between eradication schemes, variety provides a series of “natural experiments” in 86 
which different schemes adopt different tests and, thus, the international community 87 
has evidence regarding their relative merits. However, this depends on how the tests 88 
and their results are reported, and people in business rarely have time to dwell on 89 
the complexities of test performance (e.g. sensitivity and specificity). The use of 90 
different tests is not only important to the researcher, but also to the farmer, 91 
veterinarian and the eradication scheme.   92 
 93 
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We set out to try to establish relationships between reported BVDV test results. The 94 
first step in this was a systematic literature review using the Preferred Reporting 95 
Items for Systematics Reviews and Meta-Analyses (PRISMA) guidelines (Moher and 96 
others 2009). We present the results of this review followed by a discussion of the 97 
difficulties we had in using the results to establish a relationship between tests. As a 98 
consequence of the difficulties we encountered, we also examined the test results 99 
from the Scottish BVDV eradication scheme to see if the industry treated results from 100 
blood and milk tests differently. We present the results of these tests and a 101 
discussion surrounding the differences between blood and milk tests. 102 
  103 
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Materials and Methods 104 
Systematic Review 105 
In order to find as many as possible, in a repeatable and documented way,  of the 106 
papers that have published results that would help us compare test results we 107 
conducted a systematic literature review using PRISMA guidelines (Moher and 108 
others 2009). Full details of our review process are shown below: 109 
1. An advanced search was made on Web of 110 
Science http://webofknowledge.com/ 111 
2. The search we used was: 112 
(TI= ((bovine viral diarr*) OR (BVDV) OR(bovine virus diarr*)) AND 
(TI=(milk OR antibod* OR *prevalence OR eradication OR herd OR elisa)))  
3. The results were initially filtered on web of science by selecting the document 113 
type, research domain and language. 114 
i. Document Types: Article or Review 115 
ii. Research Domain: Science Technology 116 
iii. Language: English 117 
4. The results were exported in tab delimited format to Windows including their 118 
abstracts (where possible). The remaining filtering took place in Microsoft 119 
Excel. 120 
5. The results which didn’t have an abstract exported (AB column) were 121 
removed.  122 
6. The results that stemmed from a conference (CT column) were removed.  123 
7. We then removed any results which we could not access electronically or 124 
were not available in paper format from previous work. Double entries were 125 
removed. 126 
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8. Papers were then submitted to two screening questions: 127 
i. Are numerical results, a statistical model or graphs produced from 128 
which the reported results can be read? 129 
ii. Are multiple tests or multiple testing procedures used? Failing that is 130 
there an equation that can be used to compare with other results? 131 
We retained only those publications where quantitative results (e.g. number of 132 
animals positive in herd, number of PI, test scores or percentages) were 133 
available for comparison from tables or graphs. The exception was where an 134 
equation or model governing the relationship between test results, test types 135 
or PI animals was reported. 136 
 137 
For each paper we extracted the following information into tabular form: the sample 138 
types (blood/bulk milk), the tests used, how the results are presented, whether 139 
individual PI animal status was reported, whether the animals/herds tests were 140 
vaccinated, and an explanation of why we think the result can or cannot be used to 141 
link to another paper/test. As the papers were subjectively assessed there is a risk of 142 
bias across the studies from step 8 above and in extracting the results from the 143 
publication. Where the lead author was in any doubt, one of the other authors acted 144 
as a secondary reviewer. 145 
 146 
Retesting Analysis of the Scottish BVDV Eradication Scheme 147 
To establish whether the results from blood and milk antibody tests are treated 148 
differently we used the results of the BVD eradication scheme in Scotland. Results 149 
were collated and matched by the County, Parish, Holding (CPH) unique identifier. 150 
For each CPH we identified the first blood or milk antibody test and then established 151 
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the number of days for the same CPH to conduct an antigen test. Those antigen 152 
tests taking place less than nine days after the antibody test were counted as part of 153 
the same testing due to the length of time needed to return test results to the CPH in 154 
question. These resampling results are presented as a proportion of those CPHs 155 
within each class of the same initial test (milk or blood) and initial test result 156 
(negative or not negative). Only the test results recorded as “Negative” or “Not 157 
Negative” were used. To use other values would have necessitated a subjective 158 
interpretation of the overall test result. 159 
 160 
To establish if there was a statistical significant difference in the proportions of 161 
holdings retesting within 90 days (AFBI 2015, DEFRA 2015) based on the type of 162 
initial antibody test, we carried out a two-sided proportion test and a survival 163 
analysis. We selected a 90 day threshold for our analyses because this is the period 164 
within which retesting is normally recommended or required for bulk milk tests, 165 
regardless of herd status (AFBI 2015, DEFRA 2015). The CPHs were split by initial 166 
test type (milk or blood). Those CPHs that did not retest within 90 days, regardless of 167 
whether they later retested, were treated as “not retesting”.  168 
 169 
For the proportion test (Newcombe 1998) a two by two table of counts (resample 170 
before 90 days yes/no versus initial antibody test blood/milk) was constructed before 171 
we used the prop.test function in the statistical software R (R Core Team 2015) to 172 
carry out the test. The survival analysis was carried out using the survival package 173 
(Therneau 2015, Therneau and Grambsch 2000).  174 
 175 
  176 
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Results 177 
Systematic Review 178 
Table 1 shows the papers that completed the PRISMA systematic review process. 179 
For each paper we show: the sample types (blood/bulk milk), tests used, result 180 
format, whether individual PI animal status was reported, the vaccination status of 181 
the animals/herds (if reported) and description of whether the result can be used to 182 
link to another paper/test. The number of papers that remained after each stage of 183 
our process described above are shown in table 2.  184 
 185 
The papers in table 1 should allow us to compare results from different tests and 186 
different testing methods. However, we encountered significant difficulties in doing 187 
so. The most common difficulties surrounded vaccination and test variety.  188 
 189 
Retesting Analysis of the Scottish BVDV Eradication Scheme 190 
Figure 1 shows the proportion of farms (in the Scottish BVDV eradication scheme 191 
2013-2014) retesting over the year, split by the type of initial test. (Red, solid: initial 192 
negative blood test. Green, short dashed: initial not-negative blood test. Blue, 193 
dashed: initial negative milk test. Purple, long-dashed: initial not-negative milk test.)  194 
There is a clear difference between the time taken to retest. Within the first 90 days, 195 
farms are more likely (p = 0.05139 from the two-sided test of proportions) to retest 196 
following a not-negative result if the initial test was using blood testing rather than 197 
bulk milk. This is confirmed by the survival analysis which provides a relative risk of 198 
0.73 with a 95% confidence interval of (0.54, 0.98) and a rejection of the null 199 
hypothesis that the relative risk is one, based on a p-value of 0.037. 200 
 201 
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Discussion 202 
Whilst progress appears to be being made in the uptake of eradication schemes for 203 
BVDV around the world, it is still in its infancy, with more countries not yet planning 204 
such a scheme than there are countries planning, in the process of, or having 205 
achieved, eradication (Moennig and Becher 2015). We are therefore at a useful 206 
stage in the global eradication trend, because we can make use of data being 207 
reported from the different schemes from around the world. Results from schemes 208 
can be used either by aggregating data in order to achieve increased statistical 209 
power when asking epidemiological questions (e.g. does herd size affect the 210 
probability of a herd containing a PI and by how much?) or, qualitatively, by heeding 211 
the lessons learnt from the reports of successful and unsuccessful strategies. Here 212 
we describe the difficulties we had in aggregating data and present evidence from 213 
one particular scheme in which the differences in farmers’/veterinarians’ perception 214 
of the test may be influencing the time taken to retest. Comparative studies of 215 
strategies within a scheme may be even more powerful than between schemes 216 
because unknown confounders (at the scheme level) should be effectively controlled 217 
for. 218 
 219 
Aggregating data requires that data be “calibrated” into common and genuinely 220 
equivalent units (e.g. within herd seroprevalence) and therefore is dependent on 221 
comparing results from different schemes with different methods. The difficulties 222 
encountered in comparing results from different papers were mainly due to: 223 
vaccination, the variety of tests used and how their results were reported. It is clear 224 
from table 1 that some papers have vaccinated animals whilst other are 225 
unvaccinated or vaccination status is not reported.  Some eradication schemes have 226 
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banned vaccination (Lindberg and others 2006) and comparing antibody results 227 
across studies without accounting for differences in vaccination regimes risks 228 
ignoring vaccination as a clear confounder (Bauermann and others 2013, Gonzalez 229 
and others 2014a, 2014b, Humphry and others 2012, Stevens and others 2011).  230 
 231 
Whilst vaccine usage might possibly be dictated by an eradication scheme, 232 
(Lindberg and others 2006) the particular laboratory tests used could be more 233 
difficult to control. For example, within the Scottish BVDV eradication scheme the 234 
testing methods and the laboratories analysing them are controlled but not the 235 
manufacturer of the tests they use (Scottish Government 2015a). Table 1 gives  an 236 
example of the variety of tests for both blood and milk that are reported in the 237 
literature. Tests range from those used by specific laboratories to bespoke (Houe 238 
1994, Houe and Meyling 1991, Rüfenacht and others 2000). Some results are 239 
reported with insufficient detail to allow comparison. For example, the percentage 240 
inhibition results from Booth and others (2013) are reported without the control 241 
values needed to replicate them.  However, in Niskanen and others (1991) and 242 
Niskanen (1993), the control values are reported. Incomplete reporting of results 243 
may not be the authors’ choice - it may arise from the laboratory or test used. 244 
However, where full details can be made available, doing so would assist other 245 
researchers and, possibly, those in charge of eradication schemes. 246 
 247 
The accuracy and reliability of the type of test should also be considered as this can 248 
be used to estimate confidence ranges around any calibrated result from one 249 
scheme in comparison to another. For example there is good evidence (Brülisauer 250 
and others 2010, Humphry and others 2012) that using the proportion of seropositive 251 
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young-stock gives better classification of herds into  distinct antibody-level groups 252 
than bulk milk antibody scores. Figure 2 shows the frequency distribution for 253 
percentage positivity (PP) scores of bulk milk tests for 220 Scottish farms whilst 254 
figure 3 shows the frequency of 10 young stock that were BVDV seropositive in 274 255 
Scottish herds. Even with the complicating observation of a small spike at about 5 256 
seropositive animals in figure 2 (see Brülisauer and others (2010) for a full 257 
discussion) the bloods have a very clear second maximum for 9 and 10 seropositive 258 
animals, whereas the bulk milk results have no clear separation.  259 
 260 
This suggests that at herd-level, bulk milk results are more likely to produce false 261 
positives, or false negatives than is the serum screening of young-stock. Bulk milk 262 
antibody scores are not only an average of contributing animals but they also 263 
represent an average over time, reflecting historic as well as current BVDV status. 264 
The removal of PI animals will not necessarily produce an immediate change in bulk 265 
milk results (figure 4 - reproduced from Houe 1999). It is clear that even three years 266 
after the removal of the final PI animal, the bulk milk results had not changed greatly.  267 
 268 
Differences in the “performance” of a test are not just of importance to academic 269 
researchers when trying to make use of reported results from around the world. 270 
These differences, whilst appearing highly epidemiological and quantitatively 271 
technical, are also of great importance to the individual scheme itself and to the 272 
farmers and practitioners within the scheme. How farmers and their veterinarians 273 
respond to any difference in test performance (sensitivity and specificity) is hard to 274 
predict. A precautionary approach may be adopted – i.e. any bulk milk score which is 275 
just negative might be followed up with additional tests lest it be a false negative. 276 
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Conversely, a riskier approach might be that any not-negative test be considered a 277 
probable false positive. The Scottish Eradication data provides evidence that may 278 
be, in part, an example of scheme members responding to different tests according 279 
to the different test performance. 280 
 281 
Figure 1 shows that the length of time taken to retest from an initial not negative 282 
antibody test result is dependent on whether that initial test was a blood or a milk 283 
test. It is possible that farmers take a not-negative result from blood more seriously 284 
and hence retest quicker. Farmers may be taking the riskier approach with the not 285 
negative milk result which we suggested above. We should also consider whether 286 
dairy farms treat PI calves with less concern than beef farms as calves are removed 287 
from dairy herds at a younger age than in beef herds. Other explanations include the 288 
availability of follow up tests depending on whether the farm is beef or dairy, if the 289 
financial impact of a movement ban of animals is greater for beef farms or if there is 290 
more pressure within the beef sector for retesting.  291 
 292 
We do not know why those receiving not negative blood test results retest quicker 293 
but the discussion about bulk milk results is pertinent not least because the Scottish 294 
Government have removed the option for bulk milk tests from June 1st, 2015 295 
(Scottish Government 2015c). This seems understandable as eradication enters its 296 
next phase, given the importance of successful detection of the virus and the relative 297 
imperfection of the bulk milk antibody test but this policy differs from some other 298 
schemes (Hult and Lindberg 2005).  299 
 300 
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Whilst we have acknowledged the limitations of bulk milk testing, this is not to 301 
dismiss the value of testing milk from all or some cows in a herd. Milk sampling from 302 
a sub-group of milking animals can be particularly useful for testing new heifers 303 
whose antibodies provide a “signal” of recent rather than historic infection (Brownlie 304 
and Booth 2014, Houe and others 2006, Ohlson and others 2013). It is therefore 305 
reasonable that, after a scheme has effectively eradicated BVDV (and depending on 306 
vaccination regimes), the relatively convenient and cheap test that is bulk milk 307 
testing may come into its own as a first line of screening for sporadic breakdown 308 
(Booth and others 2013). 309 
 310 
There are many different tests available for BVDV and a lot of research has been 311 
published detailing test results and progress in eradication schemes (Laurens 2014, 312 
Lindberg and others 2006, Sandvik 2004). Whilst not of immediate concern to the 313 
design of a scheme, taking into account how transferable the results of that scheme 314 
are with data from other schemes has the added benefit of facilitating research 315 
based on aggregating results. When designing an eradication scheme the testing 316 
methods and individual tests available should be considered to ensure that a variety 317 
of tests within the scheme does not discombobulate the scheme itself. If the scheme 318 
is too complicated, this will only hinder the eradication.    319 
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Table 1: Details of the papers from the PRISMA systematic review. The table shows the bulk milk and 615 
blood tests used, the results format, whether or not the PI status of individual animals was reported, 616 
whether the herds/animals tested were vaccinated or not and if the authors think it possible to link the 617 
results to another test or paper. (Abbreviations other than company names, not used previously: Ab – 618 
antibody, Ag – antigen, IPMA – immunoperoxidase monolayer assay, OD – optical density, PP – 619 
percentage positive, VNT – virus neutralisation test, VI – virus isolation)  620 
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in equation no 
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BVD/MD p80 
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the VNT titre.  
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As with previous paper, cannot 
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Test) 
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No No mention of vaccination 
Relationship of bulk milk to 
serum results could provide 
link if the same test has been 
used. 
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and others 1995 No 
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No No mention of vaccination 
Could compare with results 
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Yes – (Authors’ 
own ELISA) 
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Test is author created so very 
difficult to link to a more widely 
used test. 
Sandvik  and 
Krogsrud 1995 No 
Yes – (SVANOVA 
ELISA ab test, 
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test) 
Tabulated values of 
antibody OD vs 
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No Unvaccinated 
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create link between SVANOVA 
test and antigen results. 
Schreiber and 
others 1999 No 
Yes – (Specific 
test unclear) 
Table of number of 
animals in herd with 
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Can link between other herds 
with PI animals although 
specific test used unclear. 





Yes – (IDEXX 
BVDVB 
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Table of number of 
positive spot blood 
tests and mean OD 
for the bulk milk 
tank. 
Yes 
7 out of 55 
herds 
vaccinated 
Could create link between bulk 
milk and number of positive 
young stock if same tests 
used. 
Taylor and 
others 1995 No 
Yes – (Bespoke 
Ab ELISA with 
VNT and PCR) 
Table of each pen 
with titre, ELISA, VN 
and PCR results 
with number of 







Difficult to compare as the 
ELISA created was bespoke. 
Vanderheijden 
and others 1993 No 
Yes – (Would 
appear to be 
bespoke p80 
ELISA test & SN) 
Table comparing SN 






Could compare with other 
results from same test. 
Weir and others 
2013 
Yes – (IDEXX 
ELISA) 
Yes – (IDEXX 
ELISA) 
Plot of milk S/P ratio 
vs serum S/P ratio 
with regression line. 
No Unvaccinated 
Could be used to compare 
results from previous tests if 




Yes – (Ceditest 
BVD blocking 
ELISA) 
Yes – (Ceditest 
BVD blocking 
ELISA) 
Proportion of herd 
ab+ vs status of 
herd from btm 
Yes No mention of vaccination. 
Could be used to compare with 
btm results using the same 
test. 
Zimmer and 
others 2004 No 
Yes – (Antibody 
test via VNT, 




results for each calf 
tested – titre vs 
antigen test and RT-
PCR and serological 
titre. 
Yes No mention of vaccination 
Useful comparison with other 
studies on calves and using 
the same tests. 
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Table 2: The number of papers still available to the authors after each step of the PRISMA 625 
systematics review 626 
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Figure 1: Time taken (days) from an initial antibody test to retesting for antigen, separated by 628 
initial antibody test type (milk and blood) and result (negative/not-negative). (Red, solid: initial 629 
negative blood test. Green, dotted: initial not-negative blood test. Blue, dashed: initial negative 630 
milk test. Purple, long-dashed: initial not-negative milk test.) Data is taken from the Scottish 631 
BVDV eradication scheme 2013 – 2014. 632 
 633 
Figure 2: Frequency distribution of percentage positivity results from 220 BVDV bulk milk tests 634 
from a survey of 220 Scottish Farms. Previously published in Humphry and others 2012. 635 
 636 
Figure 3: Number of seropositive animals from 10 young stock sampled in a survey of 274 637 
Scottish herds. Previously published in Brülisauer and others 2010.   638 
 639 
Figure 4: Plot of the blocking percentage of antibody reaction in a bulk milk tank against days 640 
after the removal of the last persistently infected animal. A Linear regression line is also shown. 641 
Reproduced with permission from Houe 1999.  642 
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